Celanese Acquisition of Clariant Emulsion and Powders Business to Take Effect January 1, 2003.Business Editors KRONBERG, Germany--(BUSINESS WIRE)--Dec. 23, 2002 Celanese AG (CZZ CZZ Chazan-Ziv-Zakai Bound : FSE FSE 1. feline spongiform encephalopathy. 2. focal symmetrical encephalomalacia. ; CZ: NYSE NYSE See: New York Stock Exchange ) today announced that it has completed the acquisition of Clariant AG's European emulsions and global emulsion powders business and will assume control of the business as of January 1, 2003. European Union authorities approved the transaction on December 16. Celanese announced in September its intent to purchase this business for EUR EUR In currencies, this is the abbreviation for the Euro. Notes: The currency market, also known as the Foreign Exchange market, is the largest financial market in the world, with a daily average volume of over US $1 trillion. 147 million. The acquisition builds on Celanese' strong position in the acetyls chemical chain and will be part of the company's Acetyl acetyl /ac·e·tyl/ (as´e-til) (as´e-tel?) (ah-se´til) the monovalent radical CH3COsbond, a combining form of acetic acid. a·ce·tyl n. Products segment. The new business will enable Celanese to offer a comprehensive range of value-added emulsions and emulsion powders that serve as primary ingredients in quality surface coatings, adhesives, non-woven textiles and other applications. Employing approximately 700 people, the emulsions and emulsion powders business has four production facilities servicing the unique product requirements of customers across Europe. There are also 11 sales offices and seven research and technology centers, all strategically located to provide rapid response to customers. Two of the production facilities are located in Germany and Spain, in close proximity to Celanese plants that supply chemical ingredients for emulsions. Herve Bellego, the former Head of Clariant's BU Emulsions, will head the emulsions business, which will operate under the name of Celanese Emulsions. Bellego will report to Lyndon Cole, president, Celanese Chemicals. The business will be consolidated in the acetyls segment. A process is underway to integrate the business into Celanese' organization and systems. Celanese AG is a global chemicals company with leading positions in its key products and world class process technology. The Celanese portfolio consists of five main businesses: Acetyl Products, Intermediates, Acetate Products, Ticona Technical Polymers and Performance Products. Celanese generated sales of around EUR 5.1 billion in 2001 and has about 11,700 employees. The company has 30 production plants and five research centers in 11 countries mainly in North America, Europe and Asia. Celanese AG shares are listed on the Frankfurt stock exchange Frankfurt Stock Exchange The largest of Germany's eight securities exchanges, operated by Deutsche Borse AS. (stock exchange symbol CZZ) and on the New York Stock Exchange New York Stock Exchange (NYSE) World's largest marketplace for securities. The exchange began as an informal meeting of 24 men in 1792 on what is now Wall Street in New York City. (symbol CZ). For further information please visit our website (www.celanese.com (http://www.celanese.com)).CZZ) and on the New York Stock Exchange (symbol CZ). Forward-looking statements (statements which are not historical facts) in this release are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and of 1995. Investors are cautioned that all forward-looking statements involve risks and uncertainties, including those risks and uncertainties detailed in the Company's filings with the Securities and Exchange Commission, copies of which are available from the Company. |
|
||||||||||||||||

Printer friendly
Cite/link
Email
Feedback
Reader Opinion